To test the hypothesis that human breast cancer cell lines differ in the proportion of CD44+/CD24- cells, we characterized 13 breast cancer cell lines by flow cytometry for surface expression of CD44 and CD24. This evidence concerns the gene CD44 and breast carcinoma.